Malin Parkler – Country Manager, Pfizer Sweden
Malin Parkler, country manager of Pfizer Sweden, breaks down the extensive footprint of Pfizer in Sweden across the value chain, lays down the advantages of Sweden as a research and…
Established in 1954 in Sweden, Pfizer is today the largest supplier of medical treatments in the country. With over 140 drugs and vaccines, Pfizer helps patients at all stages of life. Pfizer both prevents disease through vaccination, and treats everything from earlobes to cardiovascular disease and cancer.
Contact
Address: Vetenskapsvägen 10, 191 90 Sollentuna
Tel: 08-550 52 000 (öppen 08.00-17.00)
Fax: 08-550 520 10.
E-mail: info.sweden@pfizer.com
Malin Parkler, country manager of Pfizer Sweden, breaks down the extensive footprint of Pfizer in Sweden across the value chain, lays down the advantages of Sweden as a research and…
Having been quietly working away on its mRNA platform for years, Moderna stepped into the limelight during the COVID-19 pandemic and became a commercial-stage outfit almost overnight with its vaccine.…
Amid geopolitical tensions and a drop in foreign investments, China continues to encourage international companies to increase their Chinese footprint. At this week’s China Development Forum (CDF), CEOs from Pfizer,…
While not a major player in clinical trials at the European level, Portugal has untapped potential in this field, leveraging a first pioneering centre in Braga, the country’s strong scientific…
A roundup of the biggest pharma and healthcare stories from Turkey including the investigation of 19 pharma companies by the country’s competition watchdog; Gen Pharma Caucasus Manufacturing’s new plant in…
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) approved no less than 55 new drugs in 2023, a number surpassing that of 2022 by…
Pfizer holds a prominent position in Portugal’s pharmaceutical landscape, especially in the hospital business and for COVID-19-related products, with the emphasis now on sustainable growth post-COVID. Paulo Teixeira, a 26-year…
Last year’s COP28 summit saw a host of pharma players touting their green credentials, as PharmaBoardroom’s Louis Haynes explores here. This is an extract from our Transformative 2023: Regional Pharma…
India’s pharma industry has big dreams. At the recent Annual Summit of Organisation of Pharmaceutical Producers of India (OPPI) the nation’s policymakers, academicians, industry leaders, innovators, and scientists gathered to…
Morocco is undergoing ambitious reforms, extending universal healthcare coverage to all its citizens while resolving the shortcomings laid bare during the COVID-19 pandemic. Endorsed by a USD 450 million Program-for-Results…
Globally, while there is broad stakeholder alignment on topics like clinical trials and innovation, there is real divergence in approaches to pharmacoeconomics and health technology assessment (HTA). This is perhaps…
As North Africa cluster lead Pfizer veteran Diego Forero heads up Morocco, Tunisia, Libya, and Algeria in addition to being the country manager for Morocco. He describes the company’s 57-year…
The speed with which Pfizer-BioNTech and Moderna’s COVID-19 vaccines were brought forward may have made the mRNA technology behind them appear novel. In fact, the pioneers whose discoveries enabled the…
See our Cookie Privacy Policy Here
